Ezetimibe b-D-glucuronide

CAS: 190448-57-8

Ref. 3D-ME07193

Produktinformation

• Name: Ezetimibe b-D-glucuronide
• Synonyme: Ezetimibe phenoxy Glucuronide, 4-[(2S,3R)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxo-2-azetidinyl]phenyl β-<span class="text-smallcaps">D</span>-glucopyranosiduronic acid, 4-[(2S,3R)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxo-2-azetidinyl]phenyl-D-Glucopyranosiduronic Acid, Ezetimibe -D-Glucuronide, >85%, Ezetimibe B-D-Glucuronide, Ezetimibe glucuronide, Ezm-G, Sch 58235 Glucuronide, Sch 60663, β-<span class="text-smallcaps">D</span>-Glucopyranosiduronic acid, 4-[(2S,3R)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxo-2-azetidinyl]phenyl

Beschreibung

Ezetimibe b-D-glucuronide is a glucuronide conjugate of ezetimibe. It can be found in human serum, as well as in the liver and small intestine. Ezetimibe b-D-glucuronide has been shown to inhibit uptake of uridine into Caco2 cells, which may be due to its ability to inhibit the activity of drug transporters such as P-glycoprotein and organic anion transporting polypeptides. This drug also inhibits the production of creatine kinase in the liver and lowers cholesterol levels by inhibiting dietary cholesterol absorption. The drug interactions with statins are still unclear and require further investigation. Ezetimibe b-D-glucuronide is metabolized by glucuronidation in the liver and small intestine.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 585.55 g/mol
• Formel: C₃₀H₂₉F₂NO₉
• Reinheit: Min. 95%
• Farbe/Form: Powder